The new suite functions as a closed-loop system, integrating dedicated air handling units, nitrogen supply, and rigorous operator isolation protocols. By maintaining ISO Class 8 cleanliness standards, the facility ensures the integrity of sensitive compounds during the conversion of liquid formulations into dry powders. This process is essential for peptides, which often struggle with thermal instability and solubility issues during standard manufacturing.
Engineered for high-potency, small-volume batches, the equipment supports feed rates of up to 1 liter per hour and can manage solutions containing up to 30% water. According to Dr. Jordi Bacardit, Global Technical Lead on Peptides, the expansion allows the company to exert precise control over processing environments, directly addressing the instability inherent in modern peptide drugs. This technical capability positions Piramal to support developers in accelerating the path from development to clinical supply for complex therapeutics.

Comments (0)
No comments yet. Be the first!